Abstract
Calmodulin (CaM) is a major effector for the intracellular actions of Ca2+ in nearly all cell types. We identified a CaM-binding protein, designated regulator of calmodulin signaling (RCS). G protein-coupled receptor (GPCR)-dependent activation of protein kinase A (PKA) led to phosphorylation of RCS at Ser55 and increased its binding to CaM. Phospho-RCS acted as a competitive inhibitor of CaM-dependent enzymes, including protein phosphatase 2B (PP2B, also called calcineurin). Increasing RCS phosphorylation blocked GPCR- and PP2B-mediated suppression of L-type Ca2+ currents in striatal neurons. Conversely, genetic deletion of RCS significantly increased this modulation. Through a molecular mechanism that amplifies GPCR- and PKA-mediated signaling and attenuates GPCR- and PP2B-mediated signaling, RCS synergistically increases the phosphorylation of key proteins whose phosphorylation is regulated by PKA and PP2B.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Calcineurin / metabolism
-
Calcineurin Inhibitors
-
Calcium / metabolism*
-
Calcium Channels, L-Type / metabolism
-
Calcium Signaling
-
Calmodulin / metabolism*
-
Cyclic AMP-Dependent Protein Kinases / metabolism
-
Dopamine and cAMP-Regulated Phosphoprotein 32
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Neostriatum / cytology
-
Neostriatum / metabolism
-
Nerve Tissue Proteins / metabolism
-
Neurons / metabolism
-
Phosphoproteins / metabolism*
-
Phosphorylation
-
Receptor, Muscarinic M1 / metabolism
-
Receptors, Dopamine D1 / metabolism
-
Signal Transduction*
Substances
-
Calcineurin Inhibitors
-
Calcium Channels, L-Type
-
Calmodulin
-
Dopamine and cAMP-Regulated Phosphoprotein 32
-
Nerve Tissue Proteins
-
Phosphoproteins
-
Receptor, Muscarinic M1
-
Receptors, Dopamine D1
-
cyclic AMP-regulated phosphoprotein ARPP-21
-
Cyclic AMP-Dependent Protein Kinases
-
Calcineurin
-
Calcium